- Home
- ZLAB vs BXMT Comparison
ZLAB vs BXMT Comparison
Compare ZLAB & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- BXMT
- Stock Information
- Founded
- ZLAB 2013
- BXMT 1966
- Country
- ZLAB China
- BXMT United States
- Employees
- ZLAB N/A
- BXMT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- BXMT Real Estate Investment Trusts
- Sector
- ZLAB Health Care
- BXMT Real Estate
- Exchange
- ZLAB Nasdaq
- BXMT Nasdaq
- Market Cap
- ZLAB 4.3B
- BXMT 3.3B
- IPO Year
- ZLAB 2017
- BXMT N/A
- Fundamental
- Price
- ZLAB $38.57
- BXMT $18.65
- Analyst Decision
- ZLAB Buy
- BXMT Hold
- Analyst Count
- ZLAB 5
- BXMT 6
- Target Price
- ZLAB $54.28
- BXMT $20.10
- AVG Volume (30 Days)
- ZLAB 801.3K
- BXMT 982.3K
- Earning Date
- ZLAB 08-07-2025
- BXMT 07-30-2025
- Dividend Yield
- ZLAB N/A
- BXMT 10.07%
- EPS Growth
- ZLAB N/A
- BXMT N/A
- EPS
- ZLAB N/A
- BXMT N/A
- Revenue
- ZLAB $418,326,000.00
- BXMT $236,803,000.00
- Revenue This Year
- ZLAB $44.07
- BXMT N/A
- Revenue Next Year
- ZLAB $49.13
- BXMT $17.79
- P/E Ratio
- ZLAB N/A
- BXMT N/A
- Revenue Growth
- ZLAB 43.72
- BXMT N/A
- 52 Week Low
- ZLAB $16.01
- BXMT $16.51
- 52 Week High
- ZLAB $44.34
- BXMT $21.24
- Technical
- Relative Strength Index (RSI)
- ZLAB 57.02
- BXMT 35.80
- Support Level
- ZLAB $36.51
- BXMT $19.14
- Resistance Level
- ZLAB $41.20
- BXMT $19.88
- Average True Range (ATR)
- ZLAB 1.18
- BXMT 0.35
- MACD
- ZLAB 0.44
- BXMT -0.09
- Stochastic Oscillator
- ZLAB 70.43
- BXMT 1.35
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About BXMT Blackstone Mortgage Trust Inc.
Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.